Muscle is critical for blood sugar regulation, metabolic resilience, strength, mobility, and healthy aging
But the company expects growth to accelerate as a result of this strategic pivot in its weight loss business and executives expect Hims & Hers to hit its target of at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030
works best as an add-on inside a structured plan Semaglutide (GLP-1 medication) What it is: Prescription GLP-1 medication Primary effect: Appetite regulation and satiety Evidence for weight loss: Strong What to know: FDA-approved options exist for chronic weight management
What Does Scientific Research Say About Retatrutide (12 mg)
GLP-1/GIP medications combine GLP-1 with GIP, a second hormone that enhances insulin sensitivity and fat metabolism
As more studies unfold and demand continues to grow, patients must stay informed and cautious